Amgen vs Google: Founders, CEOs and History
Amgen was founded in 1980 by George B. Rathmann, William K. Bowes Jr. and is led by Robert A. Bradway. Google was founded in 1998 by Larry Page, Sergey Brin and is led by Sundar Pichai.
Company facts
Founders
Amgen
George B. Rathmann
Amgen, originally incorporated as Applied Molecular Genetics, was founded in 1980 not by a single scientist, but by a calculated syndicate of venture capitalists and academics trying to commercialize the brand-new science of recombinant DNA.
William K. Bowes Jr.
William K. Bowes Jr. Was the venture capital strategist whose vision catalyzed Amgen's formation.
Larry Page
Google possesses arguably the most famous, influential founding story in the history of Silicon Valley, rooted in the academic environment of Stanford University and a foundational obsession with organizing all of human knowledge.
Sergey Brin
Sergey Brin co-founded Google and played a central role in the early engineering, product, and cultural development of the company. He helped build the search technology, recruit technical talent, and preserve a culture that valued bold experiments.
CEOs and their tenures
Amgen
- George B. Rathmann1980–1988
Chief Executive Officer
George Rathmann, a physical chemist who had run research and development at Abbott Laboratories, was named Amgen's first chief executive in 1980 and worked from a small trailer so that laboratory space could go to scientists.
Source - Gordon M. Binder1988–2000
Chief Executive Officer
Gordon Binder joined Amgen as chief financial officer in 1982 and led its June 1983 initial public offering.
Source - Kevin W. Sharer2000–2012
Chief Executive Officer
Kevin Sharer joined Amgen in 1992 as president and chief operating officer and became chairman and chief executive in 2000.
Source - Robert A. Bradway2012–present
Chairman and Chief Executive Officer
Robert Bradway became chief executive on May 23, 2012, succeeding Kevin Sharer as the fourth CEO in Amgen's history, and added the chairmanship at the start of 2013.
Source
- Larry Page1998–2019
Co-founder and Former CEO
Larry Page is one of the most consequential technologists of the modern era. His initial algorithmic breakthrough organized the chaotic early internet, creating the essential infrastructure for the modern digital economy.
Source - Eric Schmidt2001–2011
Former CEO and Executive Chairman
Schmidt was the indispensable bridge between a chaotic academic research project and a globally dominant, publicly traded corporation.
Source - Sundar Pichai2015–present
CEO of Alphabet and Google
Pichai provides crucial corporate stability and pragmatic product leadership, transitioning Google from its chaotic early years into a profitable, mature corporate giant.
Source
Timeline: Amgen and Google side by side
1980Amgen
Applied Molecular Genetics is incorporated
Applied Molecular Genetics (AMGen) was incorporated on April 8, 1980 in Thousand Oaks, California, as the idea of venture capitalist William K. Bowes Jr. and a group of scientific collaborators.
1983Amgen
Nasdaq listing and the erythropoietin clone
Amgen completed its initial public offering on June 17, 1983, raising nearly US$40 million under chief financial officer Gordon Binder, and formally shortened its name to Amgen.
1984Amgen
Kirin-Amgen joint venture formed
Amgen and Kirin Brewery Company of Japan formed Kirin-Amgen in 1984 as a joint venture for the worldwide commercialization of erythropoietin.
1985Amgen
G-CSF cloned, leading to Neupogen
While Fu-Kuen Lin's team worked on erythropoietin, researcher Larry Souza and his group cloned and expressed human granulocyte colony-stimulating factor in 1985.
1989Amgen
FDA approves Epogen
The FDA approved Epogen (epoetin alfa) on June 1, 1989 for anemia in patients with chronic kidney failure on dialysis. It was the first commercial recombinant human erythropoietin. Epogen's U.S.
1991Amgen
Neupogen approved, giving Amgen a second franchise
The FDA approved Neupogen (filgrastim) in February 1991. By stimulating white blood cell production it reduced the risk of infection in cancer patients with chemotherapy-induced neutropenia.
1991Amgen
Amgen wins the erythropoietin patent fight
On March 6, 1991 the U.S. Court of Appeals for the Federal Circuit upheld the Kirin-Amgen erythropoietin patent and ruled against Genetics Institute in Amgen v. Chugai Pharmaceutical and Genetics Institute.
1998Google
Google Founded
Larry Page and Sergey Brin founded Google after developing PageRank at Stanford University. The search engine ranked web pages by link authority, which made results feel more relevant than portal-era competitors.
2000Google
AdWords Launch
Google launched AdWords in 2000 and connected advertising to search intent. Businesses could pay to appear near relevant queries, eventually through auction-based performance advertising.
2001Amgen
FDA approves Aranesp, the longer-acting EPO
Aranesp (darbepoetin alfa), an erythropoietin analogue with modified glycosylation and a longer half-life, was approved in 2001. Less frequent dosing than Epogen improved convenience and gave Amgen a newer, higher-priced product to migrate patients toward.
2002Amgen
US$16 billion Immunex acquisition brings Enbrel in-house
Amgen completed its acquisition of Immunex Corporation on July 16, 2002, the largest biotechnology deal to that point at about US$16 billion in stock and cash.
2004Google
Google IPO
Google went public in 2004 using an auction process and priced 19,605,052 shares at $85, raising about $1.67B. The IPO gave the company capital for hiring, data centers, acquisitions, and global expansion.
2005Google
Android Acquisition
Google acquired Android in 2005 to secure a role in mobile operating systems before smartphones became the main internet device. Android later gave Google global reach through manufacturers such as Samsung and many others.
2006Google
YouTube Acquisition
Google closed the YouTube acquisition in 2006 for stock valued at $1.65B. The deal gave Google a user-generated video platform, creator ecosystem, and advertising surface outside text search before online video had a mature business model.
2008Google
DoubleClick Acquisition
Google acquired DoubleClick for $3.1B to expand its advertising infrastructure beyond search. The deal strengthened display advertising, ad serving, and publisher relationships. It helped Google build a broader ad-tech stack.
2010Amgen
Prolia and XGEVA create the bone health franchise
The FDA approved Prolia (denosumab) for postmenopausal osteoporosis in June 2010 and XGEVA, the same molecule at a higher dose, for prevention of skeletal-related events in cancer patients in November 2010.
2014Google
DeepMind Acquisition
Google acquired DeepMind in 2014 to deepen its artificial intelligence research bench. DeepMind later became known for AlphaGo and other breakthroughs in reinforcement learning and scientific AI.
2015Google
Alphabet Restructuring
Google restructured into Alphabet Inc. In 2015, separating core Google from Other Bets. The move gave investors clearer visibility into Search, YouTube, Android, and Cloud economics while preserving room for Waymo, Verily, Calico, and X.
2019Amgen
US$13.4 billion purchase of Otezla from Celgene
Amgen agreed in August 2019 to buy worldwide rights to Otezla (apremilast) from Celgene for US$13.4 billion in cash, or about US$11.2 billion net of the present value of US$2.2 billion of anticipated future cash tax benefits, and closed on November 21, 2019.
2019Google
Sundar Pichai Becomes Alphabet CEO
Sundar Pichai became CEO of Alphabet in 2019 after Larry Page and Sergey Brin stepped back from daily operations. Pichai inherited a company facing cloud competition, antitrust scrutiny, privacy pressure, and rising AI expectations.
2020Amgen
Amgen joins the Dow Jones Industrial Average
Amgen replaced Pfizer in the Dow Jones Industrial Average on August 31, 2020, becoming one of the thirty components in the index. Inclusion recognized the scale Amgen had reached and added passive demand from Dow-tracking funds.
2023Amgen
US$27.8 billion Horizon Therapeutics acquisition closes
Amgen completed the acquisition of Horizon Therapeutics plc on October 6, 2023 for US$116.50 per share in cash, an equity value of about US$27.8 billion, after settling FTC litigation with a behavioral consent decree.
2023Google
Google DeepMind Integration
Alphabet combined major AI research efforts under Google DeepMind to accelerate frontier model development. The move followed competitive pressure from OpenAI and Microsoft.
2024Amgen
Imdelltra becomes the first T-cell engager for small cell lung cancer
The FDA granted accelerated approval to tarlatamab, sold as Imdelltra, on May 16, 2024 for extensive stage small cell lung cancer that has progressed on or after platinum-based chemotherapy.
2025Amgen
VESALIUS-CV extends the Repatha case to primary prevention
In November 2025 Amgen reported Phase 3 VESALIUS-CV results in more than 12,000 patients with atherosclerosis or diabetes but no prior heart attack or stroke.
2025Google
FY2025 Revenue Tops $402B
Alphabet reported FY2025 revenue of $402.836B and net income of $132.170B. The milestone showed that Search ads, YouTube, Cloud, and subscriptions kept scaling despite regulatory and AI disruption concerns.
2026Amgen
Medicare price setting reaches Enbrel and Otezla
Enbrel's negotiated Medicare price under the Inflation Reduction Act took effect on January 1, 2026, after it was named in the first round of ten drugs selected for negotiation.
Acquisitions
Amgen
- Horizon Therapeutics plc2023$27.8B
- ChemoCentryx, Inc.2022$3.7B
- Five Prime Therapeutics2021$1.9B
- Celgene Otezla Business2019$13.4B
- Onyx Pharmaceuticals, Inc.2013$10.4B
- DeCODE Genetics2012$415M
- Wiz2025$32B
- Mandiant2022$5.4B
- Fitbit2021$2.1B
- DeepMind2014$500M
- DoubleClick2008$3.1B
- YouTube2006$1.6B
Questions about Amgen vs Google
Who is the CEO of Amgen Inc. and Alphabet Inc.?
Amgen Inc. is led by Robert A. Bradway and Alphabet Inc. is led by Sundar Pichai. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Amgen Inc. founded vs Alphabet Inc.?
Amgen Inc. was founded in 1980 — 18 years before Alphabet Inc., which was founded in 1998. Amgen Inc.'s longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Alphabet Inc..
How many employees does Amgen Inc. have compared to Alphabet Inc.?
Amgen Inc. employs approximately 31,500 people, while Alphabet Inc. employs approximately 190,820. Alphabet Inc. has the larger workforce at 190,820 employees, compared to Amgen Inc.'s 31,500. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Amgen Inc. and Alphabet Inc. headquartered?
Both Amgen Inc. and Alphabet Inc. are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded Amgen Inc. and Alphabet Inc.?
Amgen Inc. was founded by George B. Rathmann, William K. Bowes Jr.. Alphabet Inc. was founded by Larry Page, Sergey Brin.
Which company has a longer operating history — Amgen Inc. or Alphabet Inc.?
Amgen Inc. has been operating for approximately 46 years, making it the more established of the two companies. Alphabet Inc. has been in operation for around 28 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Amgen vs Google overview